FI902569A0 - Producering av till gonorre anslutande pi-proteiner och vaccin. - Google Patents

Producering av till gonorre anslutande pi-proteiner och vaccin.

Info

Publication number
FI902569A0
FI902569A0 FI902569A FI902569A FI902569A0 FI 902569 A0 FI902569 A0 FI 902569A0 FI 902569 A FI902569 A FI 902569A FI 902569 A FI902569 A FI 902569A FI 902569 A0 FI902569 A0 FI 902569A0
Authority
FI
Finland
Prior art keywords
gonorre
anslutande
producering
proteiner
vaccin
Prior art date
Application number
FI902569A
Other languages
English (en)
Other versions
FI102189B1 (fi
FI102189B (fi
Inventor
Nicholas H Carbonetti
P Frederick Sparling
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of FI902569A0 publication Critical patent/FI902569A0/fi
Priority to FI945110A priority Critical patent/FI101936B1/fi
Application granted granted Critical
Publication of FI102189B1 publication Critical patent/FI102189B1/fi
Publication of FI102189B publication Critical patent/FI102189B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI902569A 1987-11-24 1990-05-23 Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämisek si FI102189B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI945110A FI101936B1 (fi) 1987-11-24 1994-10-31 Tippuribakteerien rokotteiden valmistusmenetelmä

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US12472787A 1987-11-24 1987-11-24
US12472787 1987-11-24
US24275888A 1988-09-09 1988-09-09
US24275888 1988-09-09
PCT/US1988/004225 WO1989004873A1 (en) 1987-11-24 1988-11-23 Production of gonorrheal pi proteins and vaccines
US8804225 1988-11-23

Publications (3)

Publication Number Publication Date
FI902569A0 true FI902569A0 (fi) 1990-05-23
FI102189B1 FI102189B1 (fi) 1998-10-30
FI102189B FI102189B (fi) 1998-10-30

Family

ID=26822891

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902569A FI102189B (fi) 1987-11-24 1990-05-23 Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämisek si

Country Status (12)

Country Link
US (2) US5736361A (fi)
EP (2) EP0869133A1 (fi)
JP (2) JP2803058B2 (fi)
KR (1) KR970011309B1 (fi)
AT (1) ATE169958T1 (fi)
AU (1) AU629807B2 (fi)
CA (1) CA1340506C (fi)
DE (1) DE3856240T2 (fi)
DK (1) DK175831B1 (fi)
FI (1) FI102189B (fi)
NO (1) NO302622B1 (fi)
WO (1) WO1989004873A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340506C (en) * 1987-11-24 1999-04-20 Nicholas H. Carbonetti Production of gonorrheal pi proteins and vaccines
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
ATE174625T1 (de) * 1991-03-14 1999-01-15 Imclone Systems Inc Rekombinante hybride porinepitope
WO1995004133A1 (en) * 1993-07-30 1995-02-09 The University Of North Carolina At Chapel Hill Production of gonorrheal pi proteins and vaccines in e. coli and salmonella
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
MXPA01011499A (es) * 1999-05-13 2002-06-04 American Cyanamid Co Formulaciones de combinacion de adyuvantes.
ES2327895T3 (es) * 1999-09-30 2009-11-05 Isis Innovation Limited Vacuna contra infeccion por neisseria.
JP4763210B2 (ja) * 2000-02-28 2011-08-31 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ナイセリアのタンパク質の異種発現
AU2002225972B2 (en) * 2000-11-10 2006-06-29 Wyeth Holdings Corporation Adjuvant combination formulations
EP1583517B1 (en) 2002-11-12 2019-06-12 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
PL229487B1 (pl) 2002-11-12 2018-07-31 Brigham & Womens Hospital Inc Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego
EP2455402A1 (en) 2004-04-21 2012-05-23 The Brigham and Women's Hospital, Inc. Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
US7037698B2 (en) 2004-05-19 2006-05-02 Amano Enzyme Inc. Pyrroloquinoline quinone-dependent glucose dehydrogenase
CA2731384C (en) 2008-07-21 2015-03-10 The Brigham And Women's Hospital, Inc. Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4203971A (en) * 1978-03-23 1980-05-20 Government Of The United States Neisseria gonorrhoeae vaccine
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4351761A (en) * 1978-05-15 1982-09-28 Research Corporation Purified antigen to test for Neisseria gonorrhoeae antibodies
US4220638A (en) * 1978-10-12 1980-09-02 Merck & Co., Inc. Antigenic complex from N. Gonorrhoeae
US4288557A (en) * 1978-10-12 1981-09-08 Merck & Co., Inc. Antigenic complex from N. gonorrhoeae
US4239749A (en) * 1979-09-27 1980-12-16 United States Of America Neisseria gonorrhoeae vaccine
FI63596C (fi) * 1981-10-16 1983-07-11 Orion Yhtymae Oy Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
WO1983003354A1 (en) * 1982-03-30 1983-10-13 Us Army Neisseria gonorrhoeae vaccine
EP0178863A1 (en) * 1984-10-15 1986-04-23 Schering Corporation Novel expression systems utilizing bacteriophage T7 promoters and gene sequences
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
CA1340506C (en) * 1987-11-24 1999-04-20 Nicholas H. Carbonetti Production of gonorrheal pi proteins and vaccines

Also Published As

Publication number Publication date
JPH10234388A (ja) 1998-09-08
FI102189B1 (fi) 1998-10-30
DK128490A (da) 1990-07-06
AU629807B2 (en) 1992-10-15
NO902251L (no) 1990-07-18
WO1989004873A1 (en) 1989-06-01
JPH03502881A (ja) 1991-07-04
AU2795989A (en) 1989-06-14
DK175831B1 (da) 2005-03-14
NO302622B1 (no) 1998-03-30
ATE169958T1 (de) 1998-09-15
US6068992A (en) 2000-05-30
EP0869133A1 (en) 1998-10-07
NO902251D0 (no) 1990-05-22
KR970011309B1 (ko) 1997-07-09
DK128490D0 (da) 1990-05-23
JP3388171B2 (ja) 2003-03-17
DE3856240D1 (de) 1998-09-24
CA1340506C (en) 1999-04-20
US5736361A (en) 1998-04-07
KR890701750A (ko) 1989-12-21
EP0395706A1 (en) 1990-11-07
EP0395706A4 (en) 1991-11-13
DE3856240T2 (de) 1999-05-06
FI102189B (fi) 1998-10-30
EP0395706B1 (en) 1998-08-19
JP2803058B2 (ja) 1998-09-24

Similar Documents

Publication Publication Date Title
FI902569A0 (fi) Producering av till gonorre anslutande pi-proteiner och vaccin.
EP0192392A3 (en) Insulin receptor, its purification, its production in recombinant cells, dna therefor, antibodies to insulin receptor and their preparation, and pharmaceutical compositions containing them
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
FI101632B1 (fi) Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä
ATE120487T1 (de) Therapeutische zusammensetzungen gegen streptokokken-infektionen, transformierte wirte, verfahren zur immunisierung und gentechnologisch hergestellte produkte.
RU94046017A (ru) Нуклеиновые кислоты, вектор, клетка или трансгенный организм, синтетические полипептиды, способ получения синтетического пептида, вакцинная композиция, применение нуклеиновой кислоты, способ стимуляции иммунной реакции, олигосахарид
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
SE8703539D0 (sv) Artificiell gen och proteinprodukt
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
FR2726472B1 (fr) Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
FI924457A (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
ATE89317T1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
SE8105516L (sv) Syntetisk dna och forfarande for framstellning derav
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DE69839848D1 (de) Nicht identische gene und ihre anwendung in verbesserten molekularen adjuvanten
SE8601940D0 (sv) Preparation of fused proteins, antibodies and processes therefor
DK0629238T3 (da) Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi
GR3036249T3 (en) Coccidiosis poultry vaccine
DE69021886D1 (de) Äusseres membranprotein p1 und peptide von haemophilus influenzae typ b.
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
KR890002399A (ko) 하이브리드 인터페론 및 재조합 dna기술을 이용한 그의 제조방법
RU95101019A (ru) Способ получения фактора некроза опухоли, фактор некроза опухоли, днк, клетка, композиция

Legal Events

Date Code Title Description
FG Patent granted

Owner name: THE UNIVERSITY OF NORTH CAROLINA

MA Patent expired